Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,926,336 Beta-lactamase inhibitors
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit...
US-9,926,335 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and...
US-9,926,334 Compositions to detect remnant cancer cells
Disclosed are compounds, compositions and methods for detecting remnant cancer cells in a tissue sample.
US-9,926,333 Flap modulators
The present invention relates to compounds of Formula (I), ##STR00001## or a form thereof, wherein ring A, R.sub.1, L and R.sub.2 are as defined herein, useful...
US-9,926,332 Dihydro-oxazinobenzodiazepine compounds, a process for their preparation and pharmaceutical compositions...
Compounds of formula (I) ##STR00001## having a selective dual action on the central GABAergic system, and a process for their preparation and to ...
US-9,926,331 Method of preparing anhydrosugar alcohol using additive for prohibiting polymerization by dehydration
The present invention relates to a method for producing anhydrosugar alcohol using an organic additive having one hydroxyl group. The present invention makes it...
US-9,926,330 Inhibitors of IRAK4 activity
The present invention relates to inhibitors of IRAK4 of Formula I and provides compositions comprising such inhibitors, as well as methods therewith for...
US-9,926,329 Acetate salt of buprenorphine and methods for preparing buprenorphine
The present disclosure provides acetate salts of buprenorphine, and its anhydrates, solvates, hydrates, and crystalline forms thereof, where the acetate salts...
US-9,926,328 Crystalline, anhydrous forms of oxymorphone hydrochloride
Crystalline, anhydrous hydrochloride salts of 4,5.alpha.-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) are disclosed and three polymorphic forms...
US-9,926,327 Process for preparing 7H-pyrrolo[2,3-D]pyrimidine compounds
Described herein are improved processes for the preparation of the 7H-pyrrolo[2,3-d]pyrimidine compound, ...
US-9,926,326 Substituted thioxanthenone autophagy inhibitors
Autophagy inhibitors useful for the treatment of cancer and other diseases are described. The autophagy inhibitors are a compound of formula: I wherein R.sup.1...
US-9,926,325 NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors...
The present invention is directed to novel compounds of formula I ##STR00001## and their use as therapeutic compounds.
US-9,926,324 Heteroaromatic compounds as PI3 kinase modulators and methods of use
The present invention provides heteroaromatic derivatives and pharmaceutical acceptable salts and formulations thereof useful in modulating the protein kinase...
US-9,926,323 Folate derivatives, useful in particular in the context of the folate assay
Use of a folate derivative to assay in vitro the folate in a sample such as a biological sample.
US-9,926,322 Purinone derivative
Compounds represented by general formula (I) (all of the symbols in the formula conform to the definitions in the Description) are compounds that, in addition...
US-9,926,321 Hsp90 inhibitors
The disclosure relates to Compounds of Formulae (IA) and (IB), and pharmaceutically acceptable salts thereof wherein Z.sub.1, Z.sub.2, Z.sub.3, Xa, Xb, Xc, Xd,...
US-9,926,320 Purine diones as Wnt pathway modulators
The invention relates to the use of compounds of general structure (I) in modulation of the Wnt pathway [Formula should be inserted here] wherein R.sup.1,...
US-9,926,319 Pyridyl piperidines
The invention provides novel substituted pyridyl piperidine compounds according to Formula (I), their manufacture and use for the treatment of ...
US-9,926,318 Tetracyclic autotaxin inhibitors
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such...
US-9,926,317 Inhibitors of the renal outer medullary potassium channel
The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The...
US-9,926,316 Antitumor derivatives for differentiation therapy
Imidazopyridine derivatives according to formula I are described ##STR00001## wherein X is selected from CH, N, S, and O, Y is selected from S, CO, and O,...
US-9,926,315 Triazolopyridine compounds and methods for the treatment of cystic fibrosis
The invention relates to a compound of Formula I or IA and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective...
US-9,926,314 Compounds and compositions for the treatment of parasitic diseases
The present invention provides compounds of formula I: ##STR00001## or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the...
US-9,926,313 Imidazopyridine derivatives as modulators of TNF activity
A series of substituted 3H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the...
US-9,926,312 4-azaindole derivatives
4-Azaindole derivatives which are modulators of muscarinic acetylcholine receptor (mAChR) M1 and which may be effective for the prevention or disease modifying...
US-9,926,311 Heteroaryl carboxamides
The invention relates to novel heteroaryl carboxamides, a process for their preparation, and pharmaceutical compositions containing them. These materials are...
US-9,926,309 Pi-kinase inhibitors with anti-infective activity
Compounds and methods are provided for the treatment of pathogen infections. In some embodiments, the anti-infective compounds have broad spectrum activity...
US-9,926,308 N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof
Compounds of formula I ##STR00001## wherein R.sup.1, L.sup.P, n, HetAr.sup.1, and HetAr.sup.2 are as defined herein, and salts thereof, pharmaceutical...
US-9,926,307 Compounds
The present invention relates to novel compounds and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention...
US-9,926,306 Inhibition of MCL-1 and/or BFL-1/A1
This disclosure features compounds and pharmaceutically acceptable salts thereof that inhibit MCL-1 and/or BFL-1/A1 and compositions containing the same. This...
US-9,926,305 Salts
Salts of 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[- (1R)-4-(trifluoromethyl) ...
US-9,926,304 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof
Disclosed are 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones represented by the Formula (I): ##STR00001## wherein Ar, R.sub.1-R.sub.6 are defined herein....
US-9,926,303 Processes of synthesizing dihydropyridophthalazinone derivatives
Provided herein are processes for synthesizing dihydropyridophthalazinone derivatives, such as for example, ...
US-9,926,302 Heteroaryl substituted heterocyclyl sulfones
The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these...
US-9,926,301 Bipyrazole derivatives as JAK inhibitors
The present invention provides compounds of Formula I: ##STR00001## or pharmaceutically acceptable salts thereof, as well as their compositions and methods of...
US-9,926,300 5-acylsulfanyl-histidine compounds as precursors of the corresponding 5-sulfanylhistidines and their disulfides
The invention relates to a compound of the 5-acylsulfanyl-histidine type and the derivatives thereof, of general formula (I), wherein R1 to R3=H, alkyl,...
US-9,926,299 Inhibitors of bruton's tyrosine kinase
The invention provides novel poly-substituted 5-membered heterocyclic compounds represented by Formula (IV), or a pharmaceutically acceptable salt, solvate,...
US-9,926,298 Heterocyclic compounds and use thereof
Heterocyclic compounds of Formula (I) shown herein. Also disclosed are pharmaceutical compositions containing the heterocyclic compounds and methods of using...
US-9,926,297 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4...
US-9,926,296 Process for the preparation of polymorphic forms of nilotinib hydrochloride
A process for preparing Nilotinib hydrochloride Form R5 and Form R6 comprises: step a) providing a solution of Nilotinib free base in acetic acid and optionally...
US-9,926,295 Potent and selective inhibitors of hepatitis C virus
The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other...
US-9,926,294 Pesticidally active heterocyclic derivatives with sulphur containing substituents
Compounds of formula (I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts salts, stereoisomers, enantiomers,...
US-9,926,293 Multivalent RAS binding compounds
The present invention provides, inter alia, compounds having the structure: ##STR00001## wherein R.sub.7, R.sub.8 and n are as disclosed herein, that...
US-9,926,292 Pyridinyl derivatives, pharmaceutical compositions and uses thereof
The invention relates to new pyridinyl derivatives of the formula ##STR00001## wherein R.sup.1 and A are as defined in the description and claims, to their use...
US-9,926,291 Synthesis of thiohydantoins
A novel synthesis of the anti-androgen, A52, which has been found to be useful in the treatment of prostate cancer, is provided. A52 as well as structurally...
US-9,926,290 Inhibitors of INV(16) leukemia
This invention describes the development of targeted small molecule inhibitors of the inv(16) fusion, the causative agent in .about.12% of acute myeloid...
US-9,926,289 Compositions, apparatus, systems, and methods for resolving electronic excited states
The present disclosure relates, according to some embodiments, to molecules, including conjugated fused polycyclic molecules, that may receive excited state...
US-9,926,288 Five-membered cyclic biscarbonates bearing amide linkages, their preparation and their uses for the preparation...
A compound is of formula (I): ##STR00001## in which A.sub.1 and A.sub.1' are independently from each other a linear or branched alkylene radical including...
US-9,926,287 Purification of taxanes
A method of crystallizing docetaxel is disclosed. The method comprises (a) combining docetaxel and at least one solubilizing solvent to obtain a solution,...
US-9,926,286 Vortioxetine intermediate and synthesis process thereof
The present invention provides a new intermediate II and a method for synthesizing the same. The method comprises: (a) firstly diazotizing a compound of formula...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.